"Pharmacodynamic Comparison of Omeprazole Versus Pantoprazole on Platelet Reactivity in Patients With Acute Coronary Syndromes on Dual Antiplatelet Therapy With New P2Y12 Inhibitors" -Trial dOPPLER-

NCT02028234 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Pantoprazole,
DRUG: Omeprazole

Sponsor

University of Roma La Sapienza